Skip to main content

Paul Comment On Regulatory Notice 21-19

Of particular interest is the section on Synthetic Short Positions. It seems that approved participants can use synthetics to improve market liquidity, but it also creates a problem of diluting the stock when the shorts fail to deliver. Would position reporting also help to track FTD's better and implement some regulation to have those failures sufficiently resolved before more synthetics are allowed to be created? I understand this could squeeze the shorts a bit, but it seems to make sense in terms of correctly managing scalability.

Regulatory Notice 21-20

Summary

FINRA warns member firms of an ongoing phishing campaign that involves fraudulent emails (see sample in Appendix) purporting to be from FINRA and using the domain name “@gateway-finra.org.” The email asks the recipient to click a link to “view request” and provide information to “complete” that request, noting that “late submission may attract penalties.”

FINRA recommends that anyone who clicked on any link or image in the email immediately notify the appropriate individuals in their firm of the incident.

Todd Hill Comment On Regulatory Notice 21-19

Short selling, when done ethically for the right reasons, provides an important market balance. However, it is obvious given events of the last several months that some entities are engaged in naked short selling and market manipulation. Because of the current lack of oversight, lack of detailed reporting, and the other obvious problems those entities are causing massive chaos. This kind of predatory stock dilution cannot be allowed.

Amy W Comment On Regulatory Notice 21-19

Hello, I wholeheartedly support FINRA's step toward a slightly more transparent system. FINRA requests comment on whether FINRA should publish on the FINRA website short interest data for all equity securities (listed and unlisted). • Yes, absolutely all short interest data should be published. FINRA requests comment on whether the potential short interest enhancements discussed above would be equally beneficial for both OTC equity securities and exchange-listed equity securities.